Correlation Between ManifestSeven Holdings and Cannara Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ManifestSeven Holdings and Cannara Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ManifestSeven Holdings and Cannara Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ManifestSeven Holdings and Cannara Biotech, you can compare the effects of market volatilities on ManifestSeven Holdings and Cannara Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ManifestSeven Holdings with a short position of Cannara Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of ManifestSeven Holdings and Cannara Biotech.

Diversification Opportunities for ManifestSeven Holdings and Cannara Biotech

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between ManifestSeven and Cannara is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding ManifestSeven Holdings and Cannara Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cannara Biotech and ManifestSeven Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ManifestSeven Holdings are associated (or correlated) with Cannara Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cannara Biotech has no effect on the direction of ManifestSeven Holdings i.e., ManifestSeven Holdings and Cannara Biotech go up and down completely randomly.

Pair Corralation between ManifestSeven Holdings and Cannara Biotech

If you would invest  58.00  in Cannara Biotech on September 4, 2024 and sell it today you would earn a total of  1.00  from holding Cannara Biotech or generate 1.72% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy96.88%
ValuesDaily Returns

ManifestSeven Holdings  vs.  Cannara Biotech

 Performance 
       Timeline  
ManifestSeven Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ManifestSeven Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, ManifestSeven Holdings is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
Cannara Biotech 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Cannara Biotech are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile technical and fundamental indicators, Cannara Biotech reported solid returns over the last few months and may actually be approaching a breakup point.

ManifestSeven Holdings and Cannara Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ManifestSeven Holdings and Cannara Biotech

The main advantage of trading using opposite ManifestSeven Holdings and Cannara Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ManifestSeven Holdings position performs unexpectedly, Cannara Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cannara Biotech will offset losses from the drop in Cannara Biotech's long position.
The idea behind ManifestSeven Holdings and Cannara Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Valuation
Check real value of public entities based on technical and fundamental data
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Bonds Directory
Find actively traded corporate debentures issued by US companies